{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:16:37Z","timestamp":1783426597762,"version":"3.54.6"},"reference-count":52,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.peptides.2013.12.018","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T00:00:27Z","timestamp":1389139227000},"page":"143-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The severity of coronary artery disease and reversible ischemia revealed by N-terminal pro-brain natriuretic peptide in patients with unstable angina and preserved left ventricular function"],"prefix":"10.1016","volume":"52","author":[{"given":"Luhong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaren","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2013.12.018_bib0005","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.amjcard.2012.05.014","article-title":"Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction","volume":"110","author":"Anjan","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.peptides.2013.12.018_bib0010","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.atherosclerosis.2009.01.033","article-title":"Human coronary atherosclerosis modulates cardiac natriuretic peptide release","volume":"206","author":"Barbato","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.peptides.2013.12.018_bib0015","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1161\/01.CIR.0000103681.04726.9C","article-title":"B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study","volume":"108","author":"Bibbins-Domingo","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2013.12.018_bib0020","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/002215540205000606","article-title":"Natriuretic peptide system gene expression in human coronary arteries","volume":"50","author":"Casco","year":"2002","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.peptides.2013.12.018_bib0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijcard.2011.01.014","article-title":"Expression of B-type natriuretic peptide forms in ischemic human hearts","volume":"158","author":"Cortes","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.peptides.2013.12.018_bib0030","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(97)06031-5","article-title":"Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care","volume":"350","author":"Cowie","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2013.12.018_bib0035","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.CIR.88.2.461","article-title":"Comparative effects of ischemia and hypoxemia on left ventricular systolic and diastolic function in humans","volume":"88","author":"De Bruyne","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2013.12.018_bib0040","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.peptides.2013.12.018_bib0045","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ccd.1810080605","article-title":"Reproducibility of coronary arteriographic reading in the coronary artery surgery study (CASS)","volume":"8","author":"Fisher","year":"1982","journal-title":"Cathet Cardiovasc Diagn"},{"key":"10.1016\/j.peptides.2013.12.018_bib0050","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/eurheartj\/ehl001","article-title":"Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European Society of Cardiology","volume":"27","author":"Fox","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.peptides.2013.12.018_bib0055","first-page":"106","article-title":"Rapid ambulation after coronary angiography via femoral artery access: a prospective study of 1000 patients","volume":"18","author":"Gall","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.peptides.2013.12.018_bib0060","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","article-title":"A more meaningful scoring system for determining the severity of coronary heart disease","volume":"51","author":"Gensini","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.peptides.2013.12.018_bib0065","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1096\/fj.02-0796fje","article-title":"Increased cardiac BNP expression associated with myocardial ischemia","volume":"17","author":"Goetze","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.peptides.2013.12.018_bib0070","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1161\/01.CIR.92.6.1558","article-title":"Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction","volume":"92","author":"Hama","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2013.12.018_bib0075","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.peptides.2013.12.018_bib0080","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1253\/circj.69.1472","article-title":"N-terminal pro-B-type natriuretic peptide predicts significant coronary artery lesion in the unstable angina patients with normal electrocardiogram, echocardiogram, and cardiac enzymes","volume":"69","author":"Hong","year":"2005","journal-title":"Circ J"},{"key":"10.1016\/j.peptides.2013.12.018_bib0085","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00380-010-0080-6","article-title":"A slightly elevated level of N-terminal pro-brain natriuretic peptide can predict coronary artery disease in a population with normal left ventricular function","volume":"26","author":"Ikeda","year":"2011","journal-title":"Heart Vessels"},{"key":"10.1016\/j.peptides.2013.12.018_bib0090","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0735-1097(02)01986-1","article-title":"N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation","volume":"40","author":"Jernberg","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.peptides.2013.12.018_bib0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCINTERVENTIONS.110.959148","article-title":"Validation of intravascular ultrasound-derived parameters with fractional flow reserve for assessment of coronary stenosis severity","volume":"4","author":"Kang","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.peptides.2013.12.018_bib0100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2169\/internalmedicine.52.8704","article-title":"Determination of the B-type natriuretic peptide level as a criterion for abnormalities in japanese individuals in routine clinical practice: the J-ABS Multi-Center Study (Japan Abnormal BNP Standard)","volume":"52","author":"Kawai","year":"2013","journal-title":"Intern Med"},{"key":"10.1016\/j.peptides.2013.12.018_bib0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0002-8703(96)90396-8","article-title":"Increased plasma levels of B-type natriuretic peptide in patients with unstable angina","volume":"132","author":"Kikuta","year":"1996","journal-title":"Am Heart J"},{"key":"10.1016\/j.peptides.2013.12.018_bib0110","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0735-1097(10)80319-5","article-title":"Cognition in the era of technology: seeing the shades of gray","volume":"16","author":"Klocke","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.peptides.2013.12.018_bib0115","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/eurheartj\/ehn045","article-title":"Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve","volume":"29","author":"Koo","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.peptides.2013.12.018_bib0120","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jcin.2011.12.014","article-title":"Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study","volume":"5","author":"Leone","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.peptides.2013.12.018_bib0125","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00392-009-0056-7","article-title":"Adenosine-induced maximal coronary hyperemia for myocardial fractional flow reserve measurements: comparison of administration by femoral venous versus antecubital venous access","volume":"98","author":"Lindstaedt","year":"2009","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.peptides.2013.12.018_bib0130","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0002-8703(98)70041-9","article-title":"Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction","volume":"135","author":"Maeda","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.peptides.2013.12.018_bib0135","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0733-8651(05)70243-5","article-title":"B-type natriuretic peptide in the diagnosis and management of congestive heart failure","volume":"19","author":"Maisel","year":"2001","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.peptides.2013.12.018_bib0140","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1067\/mhj.2001.113215","article-title":"Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction","volume":"141","author":"Maisel","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.peptides.2013.12.018_bib0145","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.jacc.2007.02.064","article-title":"Percutaneous coronary revascularization reduces plasma N-terminal pro-B-type natriuretic peptide concentration in stable coronary artery disease","volume":"49","author":"McClure","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.peptides.2013.12.018_bib0150","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijcard.2009.03.012","article-title":"Ischemia triggers BNP expression in the human myocardium independent from mechanical stress","volume":"143","author":"Mollmann","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.peptides.2013.12.018_bib0155","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1172\/JCI115146","article-title":"Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide","volume":"87","author":"Mukoyama","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.peptides.2013.12.018_bib0160","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1172\/JCI118162","article-title":"Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an emergency cardiac hormone against ventricular overload","volume":"96","author":"Nakagawa","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.peptides.2013.12.018_bib0165","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1210\/endo-126-4-2225","article-title":"Rat brain natriuretic peptide\u2013tissue distribution and molecular form","volume":"126","author":"Ogawa","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2013.12.018_bib0170","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/1741826711406608","article-title":"B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function","volume":"19","author":"Palazzuoli","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.peptides.2013.12.018_bib0175","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/hrt.2008.145425","article-title":"Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease","volume":"95","author":"Peer","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.peptides.2013.12.018_bib0180","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1056\/NEJM199606273342604","article-title":"Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses","volume":"334","author":"Pijls","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.peptides.2013.12.018_bib0185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2010.04.012","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study","volume":"56","author":"Pijls","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.peptides.2013.12.018_bib0190","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.peptides.2013.01.011","article-title":"Increased plasma levels of intermedin and brain natriuretic peptide associated with severity of coronary stenosis in acute coronary syndrome","volume":"42","author":"Qin","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2013.12.018_bib0195","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1590\/S0066-782X2012005000050","article-title":"Prognostic value of B-type natriuretic peptide in the mortality of patients with acute coronary syndrome","volume":"99","author":"Scotti","year":"2012","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.peptides.2013.12.018_bib0200","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/clc.20569","article-title":"N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study","volume":"32","author":"Singh","year":"2009","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.peptides.2013.12.018_bib0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijcard.2008.04.024","article-title":"Use of changes in B-type natriuretic peptides to detect ischemia in selected patients","volume":"136","author":"Staub","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.peptides.2013.12.018_bib0210","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/clc.4960231016","article-title":"Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty","volume":"23","author":"Tateishi","year":"2000","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.peptides.2013.12.018_bib0215","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.jacc.2009.11.096","article-title":"Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation","volume":"55","author":"Tonino","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.peptides.2013.12.018_bib0220","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1161\/CIRCULATIONAHA.109.872358","article-title":"Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease","volume":"120","author":"Watkins","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2013.12.018_bib0225","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jacc.2007.11.054","article-title":"N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission","volume":"51","author":"Weber","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.peptides.2013.12.018_bib0230","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ahj.2004.04.021","article-title":"N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris","volume":"148","author":"Weber","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.peptides.2013.12.018_bib0235","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/hrt.2005.071233","article-title":"Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine","volume":"92","author":"Weber","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.peptides.2013.12.018_bib0240","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1540-8183.2011.00697.x","article-title":"N-terminal pro-B-type natriuretic peptide is associated with severity of the coronary lesions in unstable angina patients with preserved left ventricular function","volume":"25","author":"Wei","year":"2012","journal-title":"J Intervent Cardiol"},{"key":"10.1016\/j.peptides.2013.12.018_bib0245","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2362.2007.01731.x","article-title":"N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis","volume":"37","author":"Wolber","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.peptides.2013.12.018_bib0250","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/01.CIR.90.1.195","article-title":"Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure","volume":"90","author":"Yasue","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2013.12.018_bib0255","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/eurheartj\/ehq259","article-title":"Three-dimensional and two-dimensional quantitative coronary angiography, and their prediction of reduced fractional flow reserve","volume":"32","author":"Yong","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.peptides.2013.12.018_bib0260","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/01.CIR.87.2.464","article-title":"Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure","volume":"87","author":"Yoshimura","year":"1993","journal-title":"Circulation"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978114000023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978114000023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T19:40:58Z","timestamp":1565034058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978114000023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":52,"alternative-id":["S0196978114000023"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2013.12.018","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The severity of coronary artery disease and reversible ischemia revealed by N-terminal pro-brain natriuretic peptide in patients with unstable angina and preserved left ventricular function","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2013.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}